Meet The Company Developing Innovative Peyote-Based Treatments For Addiction, Anxiety, And Depression

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Claire Stawnyczy, CEO of Lophos Pharmaceuticals Corp. was a guest speaker at Benzinga’s Psychedelics Capital Conference on April 19, 2022. 

Lophos Pharma is a pioneering biosciences company cultivating more sustainably harvested peyote-derivatives. It’s researching a range of physical and mental health applications for the plant that has a long history of use in traditional indigenous medicine.

Watch the full interview here.

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Image provided by Pixabay

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: PsychedelicsMarketsBenzinga Psychedelic Capital ConferenceLophos PharmaPartner Content
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!